ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 129 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,269 | -58.3% | 89,050 | -40.9% | 0.00% | -66.7% |
| Q2 2023 | $209,466 | +142.1% | 150,695 | +177.0% | 0.00% | +200.0% |
| Q1 2023 | $86,506 | -8.9% | 54,406 | +256.8% | 0.00% | 0.0% |
| Q4 2022 | $95,008 | -58.2% | 15,250 | -77.5% | 0.00% | -66.7% |
| Q3 2022 | $227,227 | +112.4% | 67,840 | +303.8% | 0.00% | +50.0% |
| Q2 2022 | $107,000 | -52.4% | 16,800 | +247.6% | 0.00% | -66.7% |
| Q2 2019 | $225,000 | – | 4,833 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |